Fecal Microbiota Transplantation May Help Cancer Patients Avoid Steroids for Immunotherapy-Related Colitis
Source Summary
Researchers at The University of Texas MD Anderson Cancer Center found that fecal microbiota transplantation (FMT) may help cancer patients with immunotherapy-related colitis avoid the need for steroids and other immunosuppressive treatments. The approach targets the gut microbiome to address this side effect of cancer immunotherapy.
Why it matters
Immunotherapy-related colitis is a significant side effect of cancer treatment, and FMT offers a potential alternative to immunosuppressive medications that may compromise cancer treatment efficacy.
